Pyxis Oncology, Inc.
Pyxis Oncology, Inc.（PYXS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pyxs · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$5.50
+225.4% upside
Low
$5.00
Median: $5.5 · Last Close: $1.69
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.50
225.4% upside
High Target
$6
255.0%
Low Target
$5
195.9%
Current Price
$1.69
as of today
Based on analyst price targets, the PYXS stock price prediction for the next 12 months ranges from $5 to $6. The consensus PYXS price forecast of $5.50 implies 225.4% upside from the current price of $1.69.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.61 | ↓ 5.00% |
1-day model range: $1.58–$1.63. Peak: $1.63 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PYXS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-24 | Stifel | Maintains | Buy→Buy |
| 2026-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-19 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-11-04 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | RBC Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Pyxis Oncology, Inc. (PYXS) stock. Of the recent 25 rating actions, 0 were upgrades and 1 were downgrades. 9 analysts currently cover PYXS.
分析师推荐趋势
PYXS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.7% YoY
Revenue Next Year
$4M
↑ 8063.3% YoY
EPS This Year
$-1.25
EPS Next Year
$-1.25
↑ 0.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast PYXS EPS of $-1.25 for the current fiscal year, based on estimates from 6 analysts. The PYXS revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PYXS 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PYXS 的共识目标价为 $5.50（+225.4% 上行空间），分析师共识为 Buy。
PYXS 的短期预测（明日）为 $1.61（-5.00%）。
Pyxis Oncology, Inc. 在 NASDAQ 上市，代码 PYXS。PYXS 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
PYXS 预测 · 8 个问题根据 9 位华尔街分析师，PYXS 的 12 个月平均目标价为 $5.50，最高 $6.00、最低 $5.00。若有图表，中位目标价可在上方查看。相对当前价 $1.69，隐含约 +225.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.